Old Web
English
Sign In
Acemap
>
authorDetail
>
Annalena Abendroth
Annalena Abendroth
Cancer
Cancer research
Pathology
Biology
Internal medicine
3
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact of RAS mutation subtype on clinical outcome—a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer
2019
Oncogene
Marcel Wiesweg
Stefan Kasper
Karl Worm
Thomas Herold
Henning Reis
Linda Sara
Martin Metzenmacher
Annalena Abendroth
Kaid Darwiche
Clemens Aigner
Heiner Wedemeyer
Fabian Helfritz
Martin Stuschke
Brigitte Schumacher
Peter Markus
Andreas Paul
Sven Rahmann
Kurt Werner Schmid
Martin Schuler
Show All
Source
Cite
Save
Citations (20)
Long-term outcome of patients with advanced pancreatic cancer treated with sequential chemotherapies before the era of modern combination therapy protocols
2019
Journal of Cancer Research and Clinical Oncology
Annalena Abendroth
R. Noureddine
M. Abramczyk
Andreas Paul
Guido Gerken
Kurt Werner Schmid
Peter Markus
Brigitte Schumacher
Marcel Wiesweg
Jens Köhler
M Markus
B. Mende
A Dechêne
Martin Schuler
Stefan Kasper
Show All
Source
Cite
Save
Citations (5)
STREAM: A randomized discontinuation, blinded, placebo-controlled phase II study of sorafenib (S) treatment of chemonaïve patients (pts) with metastatic uveal melanoma (MUM).
2017
Journal of Clinical Oncology
M. E. Scheulen
Eckhart Kaempgen
Ulrich Keilholz
Lucie Heinzerling
Sebastian Ochsenreither
Annalena Abendroth
Ralf A. Hilger
Matthias Grubert
Axel Wetter
Nika Guberina
Sebastian Bauer
Gerold Schuler
Norbert Bornfeld
Martin Schuler
H. Richly
Show All
Source
Cite
Save
Citations (9)
1